Objective: Preexposure prophylaxis (PrEP) offers a promising new approach to HIV
prevention. This systematic review and meta-analysis evaluated the evidence for use of oral …

Antiretroviral preexposure prophylaxis (PrEP; emtricitabine and tenofovir disoproxil fumarate
[Truvada]) prevents HIV without penalizing sexual pleasure, and may even enhance …

Abstract Background Preexposure prophylaxis (PrEP) is highly effective for preventing
human immunodeficiency virus (HIV) infection, but risk compensation (RC) in men who have …

We examined changes in sexual behavior and sexually transmitted infection (STI)
prevalence among 183 men who have sex with men (MSM) initiating pre-exposure …

Antiretroviral pre-exposure prophylaxis (PrEP) has received increasing recognition as a
viable prescription-based intervention for people at risk for HIV acquisition. However, little is …

Objective Preexposure prophylaxis (PrEP) with emtricitabine/tenofovir disoproxil fumarate
(FTC/TDF) reduced HIV acquisition in the iPrEx trial among men who have sex with men and …

Pre-exposure prophylaxis (PrEP) is a viable HIV prevention strategy but risk compensation
could undermine potential benefits. There are limited data that examine this phenomenon …

Objectives: Preexposure prophylaxis (PREP) is an emerging HIV prevention strategy;
however, many fear it may lead to neglect of traditional risk reduction practices through …

Pre-exposure prophylaxis (PrEP) is considered an effective biomedical approach for HIV
prevention. However, there is limited understanding of PrEP uptake among …

Introduction While bio‐behavioural interventions (BIs) for sexually transmitted infections
(STIs) and HIV prevention have shown their effectiveness (eg treatment for syphilis, HPV …